Cytokinetics Inc. (CYTK) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CYTK. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 467 institutions reported holding CYTK, with 160.3 million shares worth $13.6 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| T. Rowe Price | 20,677,444 | $1.8B | INCREASED |
| BlackRock | 20,094,362 | $1.7B | INCREASED |
| Vanguard | 13,965,705 | $1.2B | INCREASED |
| Wellington Management | 6,931,770 | $591M | DECREASED |
| State Street | 6,494,233 | $553M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Fady Ibraham Malik (EVP Research & Development) | EXERCISE | 3,500 | $27K | 2026-11-03 |
| Fady Ibraham Malik (EVP Research & Development) | SELL | 3,500 | $220K | 2026-11-03 |
| Fady Ibraham Malik (EVP Research & Development) | EXERCISE | 3,500 | $27K | 2026-11-03 |
| Robert I Blum (President & CEO) | EXERCISE | 7,500 | $80K | 2026-11-02 |
| Robert I Blum (President & CEO) | SELL | 7,500 | $471K | 2026-11-02 |
Recent Congressional Trades
| Member | Type | Amount | Date |
|---|---|---|---|
| Gilbert Cisneros (Democrat) | PURCHASE | $1,001 - $15,000 | 2026-09-29 |
Full institutional holdings, insider history, and congressional trades for Cytokinetics Inc. on SentiSense.